Our Team
Nick co-founded Amphix Bio in 2019 and has led the company from the initial tech transfer through to pre-clinical development.
He has 10+ years’ experience with Amphix Bio’s core technology platform, beginning with his PhD research in the Stupp Lab at Northwestern University.
Nick Sather, PhD
Co-founder &
Chief Executive Officer
Nick Sather, PhD
Oana is a proven biotech startup leader with expertise in scaling early-stage organizations, building CMC strategy for IND submissions, and establishing high-performing analytical and quality functions.
She has worked for leading Chicago-based startups, including Exicure and COUR Pharmaceuticals, and has extensive experience with nanoparticles and peptide-based therapeutics.
Oana Truica, PhD
Senior Principal Scientist
Oana Truica, PhD
Natalia specializes in neurology and immunology research and drug development.
​
She previously worked at Alector (San Francisco), where she contributed to drug development programs targeting neurodegeneration, and brings over five years of industry experience in experimental design, data analysis, and method optimization.
Natalia Franco-Hernandez, MS
Scientist
Natalia Franco-Hernandez, MS
Dr. Grynspan is the Vice President for International Relations at Northwestern University and is also a co-founder, board observer, and Secretary at Amphix Bio.
Dévora Grynspan, PhD, JD
Secretary
Dr. Dévora Grynspan, PhD, JD
Prof. Stupp is a Professor at Northwestern University and Director of the Center for Regenerative Nanomedicine. He has led award winning academic research in supramolecular chemistry and regenerative medicine for 40+ years.
He co-founded Amphix Bio based on the technology platform developed in his laboratory over two decades.
​
Samuel Stupp, PhD
Co-founder &
Chief Scientific Officer
Prof. Samuel Stupp, PhD
Charlotte leads Amphix Bio’s R&D program. Her PhD research in the Stupp Lab at Northwestern University is incorporated into the company’s bone regeneration therapy.
Prior to Amphix Bio, she worked at two biotechnology startups, where she focused on R&D, regulatory strategy, and IP research.
Charlotte Chen, PhD
Principal Scientist
Charlotte Chen, PhD
Dr. Hsu is a Professor of Orthopedic Surgery and Neurological Surgery at the Northwestern School of Medicine. He is a world-leading expert in minimally invasive procedures for spinal disorders.
Dr. Hsu has received numerous awards for his clinical work and serves on several influential boards, including the Head, Neck, and Spine Medical Committee of the NFL.
Wellington Hsu, MD
Scientific Advisor, Clinical Studies
Dr. Wellington Hsu, MD
Daniel is a Communications Specialist at Northwestern University and was previously a writer/editor for daily newspapers and trade publications covering the healthcare industry.
He manages Amphix Bio’s website and assists with writing and proofreading materials.
Daniel Allar
Communications Specialist
Daniel Allar
Seth provides experience spanning early-stage academic spinouts, translational science commercialization, and biotech operations. He previously co-founded Abbio XR, a University of Notre Dame spinout developing a self-assembling peptide delivery platform.
He holds dual graduate degrees from Notre Dame in Biochemistry and Business Administration, with a focus on Finance and Entrepreneurship.
Seth Flatt, MS, MBA
Business Operations Manager
Seth Flatt, MS, MBA
Iwona is an expert in synthetic organic and medicinal chemistry, with experience in R&D, cGMP, patent management, and agreement negotiations.
She was previously an Invention Manager at INVO, the tech transfer office at Northwestern University. She has prior experience at four biotech and chemistry startups, including one she co-founded.
Iwona Maciagiewicz, PhD
Principal Scientist
Iwona Maciagiewicz, PhD
Prof. Hsu is a Professor of Orthopedic Surgery at the Northwestern School of Medicine. She is a leading expert in the molecular mechanisms of bone growth, with extensive experience developing in vitro and in vivo preclinical models for bone regeneration.
She has collaborated with Dr. Stupp’s lab at Northwestern for over a decade to develop peptide materials for bone regeneration.
Erin Hsu, PhD
Scientific Advisor, Preclinical Studies
Prof. Erin Hsu, PhD